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Prokaryotic CRISPR-Cas adaptive immune systems insert spacers derived from 24	  
viruses and other parasitic DNA elements into CRISPR loci to provide sequence-25	  
specific immunity1,2. This frequently results in high within-population spacer 26	  
diversity3-6, but it is unclear if and why this is important. Here, we show that as a 27	  
result of this spacer diversity, viruses can no longer evolve to overcome CRISPR-28	  
Cas by point mutation, which results in rapid virus extinction. This effect arises 29	  
from synergy between spacer diversity and the high specificity of infection, 30	  
which greatly increases overall population resistance. We propose that the 31	  
resulting short-lived nature of CRISPR-dependent bacteria-virus coevolution 32	  
has provided strong selection for the evolution of sophisticated virus-encoded 33	  
anti-CRISPR mechanisms7. 34	  
 35	  
We previously reported that Pseudomonas aeruginosa strain UCBPP-PA14 evolves 36	  
high levels of CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic 37	  
Repeats; CRISPR-associated) adaptive immunity against virus DMS3vir under 38	  
laboratory conditions6. However, viruses can readily evolve to overcome sequence 39	  
specific CRISPR immunity8,9. To study how CRISPR-Cas impacts virus persistence, 40	  
we measured titers of virus DMS3vir over time upon infection of either wild type 41	  
(WT) P. aeruginosa or a functional CRISPR-Cas knock-out (CRISPR KO) strain. 42	  
Virus that infected the WT strain went extinct at 5 days post-infection (dpi) (Fig. 1A), 43	  
whereas virus infecting the CRISPR KO strain persisted in all replicates until the 44	  
experiment was terminated at 30 dpi (Fig. 1B). WT bacteria exclusively evolved 45	  
CRISPR-mediated immunity, while the CRISPR KO strain evolved immunity by 46	  
mutation, loss or masking of the receptor (i.e. surface mutation) (Extended Data Fig. 47	  
1). The observation that CRISPR-Cas drives virus extinct so rapidly was unexpected 48	  
since viruses can escape CRISPR immunity by a single point mutation8,9. 49	  
Virus extinction might result from the high level of spacer diversity that 50	  
naturally evolves upon virus exposure in this and other CRISPR-Cas systems3-6. Both 51	  
theory and data suggest that host genetic diversity can synergistically reduce the 52	  
spread of parasites if the infection process is specific (i.e. a parasite genotype can 53	  
infect a restricted number of host genotypes) and a failed infection results in parasite 54	  
death10-18; assumptions that hold for CRISPR-Cas-virus interactions. While the 55	  
protective effect of host diversity may be lost following the evolution of single viruses 56	  
that escape from multiple spacers10,17, host diversity has the additional benefit of 57	  
limiting such viral adaptation. Specifically, lower virus population sizes resulting 58	  
from host diversity11,12 reduces the probability of escape mutations, and the greater 59	  
the diversity the more escape mutations needed.  60	  
To examine these hypotheses, we generated bacterial populations in which we 61	  
manipulated the level of spacer diversity; we used 48 individual clones with CRISPR-62	  
based immunity against virus DMS3vir to generate bacterial populations with five 63	  
distinct diversity levels: monocultures or polycultures consisting of equal mixtures of 64	  
either 6, 12, 24 or 48 clones. To allow for direct comparisons, each of the 48 clones 65	  
was equally represented at each diversity level by adjusting the number of replicate 66	  
experiments accordingly. Each population was competed against a previously 67	  
described surface mutant6 in the presence or absence of virus DMS3vir and virus 68	  
levels were monitored over time. 69	  
This experiment revealed a strong inverse relationship between virus 70	  
persistence and the level of spacer diversity in the bacterial population (Fig. 2). Virus 71	  
titers remained high in 44 out of 48 replicates when the CRISPR population consisted 72	  
of a monoculture (Fig. 2A). However, as diversity increased, virus persistence 73	  
decreased (Fig. 2B-E) and virus was driven extinct rapidly and reproducibly when the 74	  
CRISPR population consisted of a 48-clone mixture (Fig. 2E). 75	  
Next, we examined the fitness consequences of generating spacer diversity. In 76	  
the absence of virus there was no significant effect of diversity on the relative fitness 77	  
associated with CRISPR-Cas compared to a resistant surface mutant (Extended Data 78	  
Fig. 2; F1, 52=3.20, p=0.08). However, in the presence of virus CRISPR-associated 79	  
fitness increased with increasing spacer diversity (Fig. 3; F4,71=40.30 p<0.0001 and 80	  
Extended Data Table 1), with mean fitness increasing 11-fold from monoculture to 81	  
the highest diversity population. In monoculture, the CRISPR population was 82	  
outcompeted by the surface mutant (rel. fitness < 1 ; T=-11.68, p<0.0001). However, 83	  
as diversity increased, the CRISPR population consistently outcompeted the surface 84	  
mutant (rel. fitness > 1; 6-clones: T=3.05, p=0.0093; 12-clones: T=3.95, p=0.0028; 85	  
24-clones: T=3.48, p=0.0088; 48-clones: T=3.06, p=0.014; all significant after 86	  
sequential Bonferroni correction), showing that the generation of spacer diversity is 87	  
an important fitness determinant of CRISPR-Cas (Fig. 3).  88	  
Given that all bacterial clones used in the experiment were initially resistant, 89	  
we hypothesized that the benefit of spacer diversity emerges from an inability of virus 90	  
to evolve escape mutants. To examine this, virus isolated from each time point (0, 16, 91	  
24, 40, 48, 64 and 72 hours post-infection) was spotted onto lawns of each of the 48 92	  
CRISPR clones. As expected, we could not detect escape virus in the ancestral virus 93	  
(Fig. 4A; left column, indicated in green). However, in 43 of the 48 CRISPR 94	  
monocultures, virus evolved within 2 days to overcome CRISPR immunity (Fig. 4A; 95	  
indicated in red). For 5 clones no escape virus could be detected, and virus went 96	  
extinct in 4 of these instances (Fig. 4A, asterisks). Three of these 5 clones carried 97	  
multiple spacers targeting the virus, which limits the emergence of escape virus16. The 98	  
emergence of escape virus decreased as diversity increased to 6, 12, 24 and 48 99	  
CRISPR alleles (Fig. 4); in the latter, no escape virus could be detected. These 100	  
phenotypic data were supported by results of deep sequencing of virus genotypes 101	  
isolated from 1 dpi: there was a significant inverse relationship between host diversity 102	  
and the accumulation of viral mutations in the target sequences (Extended Data Fig. 103	  
3). This is because virus needs to overcome multiple spacers in the diverse host 104	  
population if it is to increase in frequency (Extended Data Fig. 4). Consistent with a 105	  
lack of escape virus emerging against all host genotypes, the spacer content of mixed 106	  
populations of 6, 12, 24 and 48 clones did not increase between t=0 and t=3 107	  
(Wilcoxon Signed Rank p>0.2 for all treatments), whereas monocultures acquired 108	  
novel spacers in response to emerging escape virus (Wilcoxon Signed Rank W=333, 109	  
DF=47, p<0.0001; Extended Data Fig. 5). These data show that while escape viruses 110	  
can clearly evolve against most of the clones, escape viruses do not emerge when 111	  
these clones are mixed.  112	  
 We hypothesized that the benefit of within-population spacer diversity is 113	  
because of synergy between the different clones. However, diversity will also increase 114	  
the chance that a single clone with one or more spacers that the virus is unable to 115	  
overcome will be present in the population. Indeed, we observed 5 clones against 116	  
which escape mutants were never detected, and presence of these clones in many of 117	  
the diverse populations could explain the fitness advantage of diversity. To investigate 118	  
if synergy plays an important role in the benefit of diversity beyond this “jackpot” 119	  
effect, we compared the fitness of diverse populations with the fitness of the fittest 120	  
constituent clone, as measured in monoculture. This analysis revealed that synergism 121	  
contributed an approximately 50% growth rate advantage when in competition with 122	  
surface mutants (Mean ± SEM difference in fitness between mixtures and fittest 123	  
constituent monoculture = 0.47 ± 0.18; P < 0.01) 124	  
The short-lived nature of coevolution between CRISPR-resistant bacteria and 125	  
virus escape mutants beyond a host diversity threshold may explain the evolution of 126	  
sophisticated anti-CRISPR mechanisms to overcome CRISPR-Cas7. Indeed, a virus 127	  
carrying an anti-CRISPR gene7 was found to persist independent of CRISPR diversity 128	  
levels (Extended Data Fig. 6AB) and caused similar extinction of CRISPR-resistant 129	  
monocultures and 48-clone populations that competed against a surface mutant 130	  
(Fisher’s exact test, p=1.0 at t=1, p=0.33 at t=3 dpi; Extended Data Fig. 6C). 131	  
Finally, to test that our results were not limited to the P. aeruginosa PA14 132	  
Type I-F CRISPR-Cas system, we performed a similar experiment with Streptococcus 133	  
thermophilus DGCC7710 clones that evolved resistance against virus 2972 using a 134	  
Type II-A CRISPR-Cas system. As shown in Extended Data Fig. 7, we found a 135	  
similar effect of CRISPR resistance allele diversity on virus persistence and escape 136	  
virus emergence. However, during coevolution experiments the levels of evolved 137	  
diversity are lower in S. thermophilus (data not shown and refs. 4,5), which, 138	  
consistent with theory10,17, allows for more persistent coevolution4,5. Lower levels of 139	  
evolved spacer diversity might be due to a more weakly primed CRISPR-Cas 140	  
system19-21. 141	  
Collectively, our data demonstrate that the propensity to generate host genetic 142	  
diversity is a key fitness determinant of CRISPR-Cas adaptive immune systems 143	  
because it limits the emergence of escape virus. Consistent with the idea that it is 144	  
harder for a parasite to adapt to a heterogeneous host population22, virus rapidly 145	  
evolved high levels of infectivity on monocultures, but not on a diverse mix of the 146	  
same host genotypes. Parasites are often invoked as the selective force driving the 147	  
evolution of diversity generating mechanisms22-26. In most cases, individual-level 148	  
selection is assumed to be the driver of these traits, because individual benefits are 149	  
high, and group selective benefits would be opposed by the invasion of individuals 150	  
who do not pay the fitness costs associated with these mechanisms (e.g. sex and 151	  
increased mutation rates)26-28. In the case of CRISPR-Cas, we speculate that 152	  
population-level selection may have contributed to its evolution. First, there were 153	  
large benefits associated with synergy between diverse genotypes. Second, costs of 154	  
CRISPR-Cas are conditional on virus exposure6,29 and clones lacking CRISPR 155	  
immunity cannot invade populations (Extended Data Figs. 8-11). Third, the highly 156	  
structured nature of bacterial populations, and the resulting high relatedness, promotes 157	  
between-population selection30. Future tests of this hypothesis are needed to reconcile 158	  
the selective forces that have shaped the evolution of CRISPR-Cas systems.  159	  
Methods 160	  
Bacterial strains and viruses 161	  
P. aeruginosa UCBPP-PA14 (WT), P. aeruginosa UCBPP-PA14 csy3::LacZ 162	  
(referred to as CRISPR KO, which carries a disruption of an essential cas gene and 163	  
can therefore not evolve CRISPR immunity), the CRISPR KO-derived surface mutant 164	  
and virus DMS3vir have all been described in ref. 6 and references therein. Phage 165	  
DMS3vir+acrF1, which carries the anti-CRISPR gene acrF1 (formerly 30-35), was 166	  
made by inserting acrF1 into the DMS3vir genome using methods described in ref. 7. 167	  
Streptococcus thermophilus strain DGCC7710 and its virus 2972 have been described 168	  
in ref. 2. 169	  
 170	  
Coevolution experiments 171	  
The coevolution experiments shown in Fig. 1 were performed in glass microcosms by 172	  
inoculating 6 ml M9 supplemented with 0.2% glucose with approximately 106 colony 173	  
forming units (cfu) bacteria from fresh overnight cultures of the WT P. aeruginosa 174	  
UCBPP-PA14 or CRISPR KO strain and adding 104 plaque forming units (pfu) of 175	  
virus DMS3vir, followed by incubation at 37 ºC while shaking at 180 rpm (6 176	  
replicates). Cultures were transferred daily 1:100 to fresh broth. Virus titers were 177	  
determined at 0, 3, 5, 11, 17, 22 and 30 days after the start of the coevolution 178	  
experiment by spotting virus samples isolated by chloroform extraction on a lawn of 179	  
CRISPR KO bacteria. The analysis of virus immunity was performed by cross-streak 180	  
assay and PCR as described previously6.  181	  
 182	  
Generation of populations with different levels of CRISPR diversity 183	  
For the competition experiments, shown in Figs. 2-4 and Extended Data Figs. 2-6 and 184	  
8-11, we generated P. aeruginosa populations with varying levels of CRISPR spacer 185	  
(allele) diversity. To this end, we isolated from the 6 replicates of the coevolution 186	  
experiment (Fig. 1) a total of 48 individual clones that had acquired CRISPR 187	  
immunity against virus DMS3vir. We have previously shown that individual clones 188	  
tend to have unique spacers6. Using these 48 clones, populations with five different 189	  
levels of CRISPR spacer (allele) diversity were generated. These populations 190	  
consisted of: 1) 1 clone (a monoculture; a clonal population carrying a single spacer); 191	  
equal mixtures of 2) 6 clones; 3) 12 clones; 4) 24 clones and 5) 48 clones. In total 48 192	  
different monocultures (48 x monocultures), 8 x 6-clone populations, 4 x 12-clone 193	  
populations, 2 x 24-clone populations and 1 x 48-clone population were generated 194	  
(details of the composition of each population can be found below, under “number of 195	  
replicate experiments”).  196	  
 197	  
Competition experiments 198	  
Competition experiments were done in glass microcosms in a total volume of 6 ml 199	  
M9 supplemented with 0.2% glucose. Competition experiments were initiated by 200	  
inoculating 1:100 from a 1:1 mixture (in M9 salts) of overnight cultures of the 201	  
appropriate CRISPR population and either the surface mutant (Figs. 2-4 and Extended 202	  
Data Figs. 2, 4-6, 8) or the CRISPR KO strain (Extended Data Figs. 7-11). At the start 203	  
of each experiment 109 pfu of virus was added, unless indicated otherwise. Cultures 204	  
were transferred daily 1:100 into fresh broth. At 0 and 72 hours post-infection (hpi) 205	  
samples were taken and cells were serially diluted in M9 salts and plated on LB agar 206	  
supplemented with 50 µg.ml-1 X-gal (to allow discrimination between WT-derived 207	  
CRISPR clones (white) and CRISPR KO or surface mutant (blue)). The relative 208	  
frequencies of the WT strain were used to calculate the relative fitness (rel. fitness = 209	  
[(fraction strain A at t=x) * (1 – (fraction strain A at t=0))] / [(fraction strain A at t=0) 210	  
* (1 – (fraction strain A at t=x)]). At 0, 16, 24, 40, 48, 66 and 72 hpi, samples were 211	  
taken and chloroform extractions were performed to isolate total virus, which was 212	  
spotted on a lawn of CRISPR KO bacteria for quantification. All subsequent 213	  
statistical analyses were carried out using JMP (v12) software. 214	  
 215	  
Determination of escape virus emergence 216	  
To determine the emergence of escape virus during the competition experiments, 217	  
every isolated virus sample was spotted onto 48 different bacterial lawns, 218	  
corresponding to each of the different CRISPR clones. This procedure was done for 219	  
each of the seven time points (see above), to enable us to track the emergence of 220	  
escape virus against every individual clone over the time course of the experiment.  221	  
 222	  
Deep sequencing 223	  
Isolated phage samples from t=1 dpi of the competition experiment shown in Fig. 2-4 224	  
were used to perform deep sequencing of spacer target sites on the phage genomes. 225	  
To obtain sufficient material, phage were amplified by plaque assay on the CRISPR 226	  
KO strain. Viruses from all replicates within a single diversity treatment were pooled. 227	  
As a control, ancestral virus and escape virus from competition between sm and 228	  
monocultures of CRISPR clones 1-3 were processed in parallel. Virus genomic DNA 229	  
extraction was performed from 5 ml sample at approximately 1010 pfu/ml using the 230	  
Norgen phage DNA isolation kit, following the manufacturer’s instructions. Barcoded 231	  
Illumina Truseq Nano libraries were constructed from each DNA sample with an 232	  
approximately 350bp insert size and 2x 250bp reads generated on an Illumina MiSeq 233	  
platform. Reads were trimmed using Cutadapt v1.2.1 and Sickle v1.200 and then 234	  
overlapping reads merged using Flash v1.2.8 to create high quality sequence at 235	  
approximately 8000x coverage of DMS3vir per sample. These reads were mapped to 236	  
PA14 and DMS3vir genomes using bwa mem v0.7.12 and allele frequencies of SNPs 237	  
within viral target regions quantified using samtools mpileup v0.1.18. Further 238	  
statistical analyses was performed in R v3.2.2. Sequence data are available from the 239	  
European Nucleotide Archive under accession PRJEB12001 and analysis scripts are 240	  
available from https://github.com/scottishwormboy/vanHoute. 241	  
 242	  
Determining the acquisition of new spacers 243	  
To examine spacer acquisition during the competition experiments shown in Fig. 2-4, 244	  
we examined by PCR for each diversity treatment the spacer content of 384 randomly 245	  
isolated clones at both t=0 and t=3 (192 clones per time point). For each replicate 246	  
experiment, the difference in the total number of spacers between t=0 and t=3 was 247	  
divided by the number of clones that were examined to calculate the average change 248	  
in the number of spacers per clone. 249	  
 250	  
Number of replicate experiments 251	  
To ensure equal representation of each of the 48 clones across the different 252	  
treatments, the number of replicate experiments for a given diversity treatment was 253	  
adjusted accordingly, with a total number of replicates of at least 6 for sufficient 254	  
statistical power. Hence, competition experiments with the 1-clone (monoculture) 255	  
populations were performed in 48 independent replicates, each corresponding to a 256	  
unique monoculture of a CRISPR clone (clones 1-48; each clone is equally 257	  
represented). Competition experiments with the 6-clone populations were performed 258	  
in eight independent replicates, each corresponding to a unique polyculture population 259	  
(population 1: equal mixture of clones 1-6; population 2: clones 7-12; population 3: 260	  
clones 13-18; population 4: clones 19-24; population 5: clones 25-30; population 6: 261	  
clones 31-36; population 7: clones 37-42; population 8: clones 43-48). Competition 262	  
experiments with the 12-clone populations were also performed in eight replicates, 263	  
corresponding to 4 unique polyculture populations (replicate 1 and 2: clones 1-12; 264	  
replicate 3 and 4: clones 13-24; replicate 5 and 6: clones 25-36; replicate 7 and 8: 265	  
clones 37-48). Competition experiments with the 24-clone populations were 266	  
performed in six replicates, corresponding to 2 unique polyculture populations 267	  
(replicate 1-3: clones 1-24; replicate 4-6: clones 25-48). Competition experiments 268	  
with the 48-clone populations were performed in six replicates, each corresponding to 269	  
the same polyculture population (replicate 1-6: clones 1-48).  270	  
 271	  
Escape phage degradation and fitness 272	  
In the experiment shown in Extended Data Fig. 3, approximately 108 pfus of either 273	  
ancestral virus or escape virus, which was isolated from the competitions between 274	  
monocultures 1-6 and the surface mutant, was used to infect a monoculture of the 275	  
corresponding CRISPR clone or the 48-clone polyculture. Phage samples were taken 276	  
at 0, 9, 20 and 28 hpi by chloroform extraction and titrated on a lawn of the CRISPR 277	  
KO strain. Fitness of each of the escape phages was determined by a competition 278	  
experiment between ancestral and escape virus; a 50:50 ratio of escape and ancestral 279	  
phage (109 pfus total) was used to infect either a monoculture of the corresponding 280	  
CRISPR clone or the 48-clone polyculture. Virus samples were taken at t=0 and t=20 281	  
hpi by chloroform extraction and used in a plaque assay on CRISPR KO. Next, 282	  
individual plaques (48 plaques per replicate) were isolated and amplified on the 283	  
CRISPR KO strain. To determine the ratio of escape and ancestral virus, virus from 284	  
each individual plaque was spotted on a lawn of 1) CRISPR KO (both ancestral and 285	  
escape virus form plaques) and 2) the corresponding CRISPR immune clone (only 286	  
escape virus can form a plaque).  287	  
 288	  
Effect of spacer diversity in Streptococcus thermophilus  289	  
Streptococcus thermophilus DGCC7710 was grown in M17 medium supplemented 290	  
with 0.5% α-lactose (LM17) at 42°C. Virus 2972 was used throughout the 291	  
experiments. Virus infections were carried out using 106 pfus of phage 2972 and 292	  
10mM CaCl2 to facilitate the infection process. To obtain virus-resistant S. 293	  
thermophilus clones, a sample of virus lysate at 24 hpi was plated on LM17 agar 294	  
plates. Individual colonies were picked and PCR-screened for the acquisition of novel 295	  
spacers in each of the 4 CRISPR loci, as described in ref. 2. A total of 44 individual 296	  
clones were selected to generate 44 monocultures and a single polyculture comprised 297	  
of a mix of 44 clones. These cultures were infected with 107 pfu of virus, and samples 298	  
were taken after the indicated periods of time to isolate virus. We determined virus 299	  
titers by spotting viral dilutions on lawns of ancestral bacteria, and the emergence of 300	  
escape virus by spotting virus on lawns corresponding to each of the 44 CRISPR 301	  
resistant clones.  302	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  401	  
Figure legends 402	  
Figure 1 403	  
Evolution of CRISPR-mediated immunity leads to rapid extinction of virus. Titer 404	  
(pfu/ml) of virus DMS3vir over time upon infection of A) WT P. aeruginosa and B) 405	  
P. aeruginosa strain csy3::LacZ (CRISPR KO strain). Each line indicates an 406	  
individual replicate experiment (n=6). The limit of detection is 200 pfu/ml. 407	  
 408	  
Figure 2 409	  
Virus persistence inversely correlates with the level of spacer diversity. Virus titers 410	  
(pfu/ml) over time upon infection of a bacterial population consisting of an equal 411	  
mixture of a surface mutant and A) a monoculture with CRISPR-mediated immunity 412	  
(n=48), or polycultures with CRISPR-mediated immunity consisting of B) 6 clones 413	  
(n=8), C) 12 clones (n=8), D) 24 clones (n=6), E) 48 clones (n=6). The number of 414	  
replicates is chosen such that all clones are equally represented in each treatment. 415	  
Each line indicates an individual replicate experiment. The limit of detection is 200 416	  
pfu/ml. 417	  
 418	  
Figure 3 419	  
Relative fitness of bacterial populations with CRISPR-mediated immunity positively 420	  
correlates with increasing spacer diversity. Relative fitness of bacterial populations 421	  
with CRISPR-mediated immunity, with spacer diversity as indicated, at 3 days post-422	  
infection when competing with a surface mutant. Error bars indicate 95% confidence 423	  
intervals. 424	  
 425	  
 426	  
Figure 4 427	  
Emergence of virus that overcomes host CRISPR immunity (escape virus) during the 428	  
experiment shown in Figures 2 and 3. Each column in a table represents a time point 429	  
where virus was isolated (0, 16, 24, 40, 48, 64 and 72 hours post-infection, as 430	  
indicated below the table (in days post-infection)). Green: no escape virus. Red: 431	  
escape virus. Panels A-E correspond to each of the experiments shown in Figure 2 A-432	  
E. Bold numbers indicate replicate experiments. Numbers between parentheses 433	  
indicate the identity of the clones that are present in the CRISPR population. Asterisks 434	  
indicate that virus went extinct during the experiment. 435	  
 436	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Figure 1 438	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  474	  
Extended Data Table 1: Tukey HSD all pairwise comparisons of the data in 475	  
Figure 3. 1 = monoculture, 6 = 6-clone polyculture, 12 = 12-clone polyculture, 24 = 476	  
24-clone polyculture, 48 = 48-clone polyculture 477	  
 478	  
Extended data Figure 1 479	  
Infection with virus DMS3vir leads to rapid evolution of CRISPR-mediated immunity 480	  
in WT bacteria, while CRISPR KO bacteria primarily evolve virus immunity by 481	  
surface mutation. Percentage bacteria at 5 days post-infection that have evolved 482	  
immunity by CRISPR-Cas (white bar), surface mutation (black bar) or that have not 483	  
evolved immunity (sensitive; grey bars). Error bars indicate 95% confidence intervals 484	  
(CI).  485	  
 486	  
Extended data Figure 2 487	  
No benefit of increasing spacer diversity in the absence of virus. Relative fitness of 488	  
CRISPR immune monocultures (single spacer; low diversity) and polycultures (48 489	  
spacers; high diversity) at 3 days post-infection when competing with a surface 490	  
mutant (sm) in the absence of virus. Error bars indicate 95% CI.  491	  
 492	  
 493	  
 494	  
Comparison Difference Std Error t Ratio Prob>|t| Lower 
95% 
Upper 
95% 
1 6 -1.12680 0.2141986 -5.26 <.0001* -1.72637 -0.52724 
1 12 -1.40303 0.2141986 -6.55 <.0001* -2.00259 -0.80346 
1 24 -1.72790 0.2428783 -7.11 <.0001* -2.40775 -1.04806 
1 48 -2.35252 0.2428783 -9.69 <.0001* -3.03236 -1.67267 
6 12 -0.27622 0.2804518 -0.98 0.8612 -1.06124 0.50879 
6 24 -0.60110 0.3029225 -1.98 0.2842 -1.44901 0.24682 
6 48 -1.22571 0.3029225 -4.05 0.0012* -2.07363 -0.37780 
12 24 -0.32488 0.3029225 -1.07 0.8200 -1.17279 0.52304 
12 48 -0.94949 0.3029225 -3.13 0.0205* -1.79741 -0.10158 
24 48 -0.62462 0.3238378 -1.93 0.3119 -1.53108 0.28184 
Extended data Figure 3 495	  
Deep sequencing analysis of the frequency of mutations in the target sequence (seed 496	  
sequence and the adjoining PAM) of virus isolated at t=1 from the experiment shown 497	  
in Fig. 4. A) Frequency of point mutation in the single target sequence of a viral 498	  
population isolated from the monocultures of clones 1-3. B) Average frequency of 499	  
point mutation across all target sites in the ancestral virus genome and in the genomes 500	  
of virus from pooled samples of all replicates from a single diversity treatment. Error 501	  
bars indicate 95% (CI).  502	  
 503	  
Extended data Figure 4 504	  
Escape virus titers decline upon infection of diverse CRISPR populations despite 505	  
increased fitness over ancestral virus. Escape virus was isolated from monocultures of 506	  
clones 1-6 competing with the surface mutant at 24 hpi (Fig. 3 and Extended Data 507	  
Fig. 2). A) Virus titers (pfu/ml) over time upon infection with approximately 107 pfu 508	  
individual escape virus or ancestral virus of a bacterial population consisting of a 509	  
monoculture (dotted line) or 48-clone polyculture (solid line). B) Relative fitness of 510	  
escape virus and ancestral virus during infection of a CRISPR resistant monoculture 511	  
or polycultures consisting of 48 clones. All experiments were performed in 6 512	  
replicates. Error bars indicate 95% CI. The limit of detection is 200 pfu/ml. 513	  
 514	  
Extended data Figure 5 515	  
Diverse populations do not acquire additional spacers during the experiments shown 516	  
in Figures 2-4. For each diversity treatment we examined the spacer content of 192 517	  
randomly isolated clones at both t=0 and t=3 (384 clones in total per diversity 518	  
treatment). The change in the total number of spacers between t=0 and t=3 was 519	  
calculated independently for each replicate experiment and divided by the number of 520	  
clones that were examined. The graph indicates the average across the replicates of 521	  
the change in spacer content per clone and error bars indicate 95% CI.  522	  
 523	  
Extended data Figure 6 524	  
Persistence of phage that encodes an anti-CRISPR gene is independent of spacer 525	  
diversity. A) Virus titers (pfu/ml) over time upon infection of a bacterial population 526	  
consisting of an equal mixture of a surface mutant and A) a monoculture with 527	  
CRISPR-mediated immunity (n=48) or B) a 48-clone polyculture with CRISPR-528	  
mediated immunity (n=6). Each clone is equally represented in each treatment. Each 529	  
line indicates an individual replicate experiment. The limit of detection is 200 pfu/ml. 530	  
C) The number of replicate experiments in which the CRISPR immune population 531	  
went extinct (no detectable white colonies) at 1 and 3 dpi.  532	  
 533	  
Extended data Figure 7 534	  
Virus persistence inversely correlates with the level of CRISPR spacer diversity in 535	  
CRISPR immune populations of Streptococcus thermophilus. Virus titers (pfu/ml) 536	  
over time upon infection of a bacterial population consisting of A) a monoculture with 537	  
CRISPR-mediated immunity (n=44) or B) 44-clone polycultures with CRISPR-538	  
mediated immunity (n=28). Each clone is equally represented in each treatment. Each 539	  
line indicates an individual replicate experiment. The limit of detection is 200 pfu/ml. 540	  
C) OD600 of monocultures and polycultures at 1 and 2 days post infection. Error bars 541	  
indicate 95% confidence intervals. D) Emergence of virus mutants that overcome 542	  
CRISPR-mediated immunity after 0, 16, and 24 hours post-infection. Green indicates 543	  
no escape virus. Red indicates emergence of escape virus. All polyculture 544	  
experiments showed no escape virus. 545	  
 546	  
Extended data Figure 8 547	  
Sensitive bacteria are unable to invade bacterial populations with CRISPR-mediated 548	  
immunity in the presence of virus. Relative fitness of CRISPR populations with 549	  
indicated spacer diversity at 3 days post-infection when competing with the sensitive 550	  
CRISPR KO strain. Relative fitness of CRISPR populations decreases with increasing 551	  
spacer diversity due to the rapid virus extinction, which benefits sensitive bacteria, but 552	  
is higher than 1 in all cases. Error bars indicate 95% CI. 553	  
 554	  
Extended data Figure 9 555	  
Virus persistence inversely correlates with the level of CRISPR spacer diversity 556	  
during competition between CRISPR immune populations and the sensitive CRISPR 557	  
KO strain. Virus titers (pfu/ml) over time upon infection of a bacterial population 558	  
consisting of an equal mixture of a CRISPR KO clone and A) a monoculture with 559	  
CRISPR-mediated immunity (n=48), or polycultures with CRISPR-mediated 560	  
immunity consisting of B) 6 clones (n=8), C) 12 clones (n=8), D) 24 clones (n=6), E) 561	  
48 clones (n=6). The number of replicates is chosen such that all clones are equally 562	  
represented in each treatment. Each line indicates an individual replicate experiment. 563	  
The limit of detection is 200 pfu/ml. 564	  
 565	  
Extended data Figure 10 566	  
Emergence of virus mutants that overcome CRISPR-mediated immunity during the 567	  
experiment shown in Extended Data Figure 9. Each column in a table represents a 568	  
time point (0, 16, 24, 40, 48, 64 and 72 hours post-infection, as indicated below the 569	  
table (in days post-infection)) where virus was isolated. Green indicates no escape 570	  
virus. Red indicates emergence of escape virus. Panels A-E correspond to each of the 571	  
experiments shown in Extended Data Figure 9 A-E. Bold numbers indicate replicate 572	  
experiments. Numbers between parentheses indicate the identity of clones that are 573	  
present in a population with CRISPR-mediated immunity. Asterisks indicate replicate 574	  
experiments where virus went extinct during the experiment. 575	  
 576	  
Extended data Figure 11 577	  
Sensitive bacteria are unable to invade bacterial populations with CRISPR-mediated 578	  
immunity in the absence of virus, independent of the level of spacer diversity. 579	  
Relative fitness of monoculture (single spacer; low diversity) and polyculture (48 580	  
spacers; high diversity) at 3 days post-infection when competing with the CRISPR 581	  
KO strain (sensitive) in the absence of virus. Error bars indicate 95% CI.   582	  
Extended data Figure 1  583	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